Managing Clinical and Translational Research During COVID-19-Managing Clinical and Translational Research During COVID Webinar Slide Deck

Pdf Summary

This document is a summary of a presentation titled "Managing Clinical and Translational Research During COVID-19." The presenters included Christian Rolfo, MD, PhD, MBA, Dr.hc, Antoinette Wozniak, MD, FACP, FASCO, Jyoti Patel, MD, FASCO, M. Catherine Pietanza, MD, Buerkley Rose, MSN, RN, HPE, and Amy C. Moore, PhD. The presentation covered various aspects of managing clinical research during the COVID-19 pandemic.<br /><br />Antoinette Wozniak discussed the management of clinical research at the University of Pittsburgh Hillman Cancer Center. They outlined a tiered system for stratifying and managing risk during the pandemic, with studies providing high direct benefit or being of high public health priority given priority. Protocols that may pose a risk to participants or have delayed clinical discovery were also considered. The presenter emphasized the importance of following guidance provided by the NCI Cancer Therapy Evaluation Program (CTEP) and the FDA.<br /><br />Jyoti Patel focused on the impact of the COVID-19 pandemic on ongoing research and the challenges faced. They addressed questions such as what to do with ongoing research, the potential benefits and risks of continuing trials, and the need to learn from this crisis to improve future research.<br /><br />M. Catherine Pietanza discussed the industry perspective on moving forward with research during the pandemic. They emphasized the importance of continuing enrollment in clinical trials, ensuring the supply chain of investigational agents, and implementing trial procedures through alternative methods if necessary. They also highlighted the need for flexibility in trial conduct and adherence to safety monitoring.<br /><br />Buerkley Rose provided a nursing perspective on managing clinical trials during the pandemic. They discussed the challenges faced by oncology nurses in adapting to new information, reallocation of resources, and implementing new policies. They also highlighted the impact of the pandemic on clinical trial participation and emphasized the importance of communication, telehealth resources, and patient education.<br /><br />Amy C. Moore discussed the efforts of lung cancer patient advocacy groups in addressing the needs of the community during the pandemic. They highlighted the evolving concerns and needs of lung cancer patients, including access to care, fears of exposure, and the long-term implications of the pandemic.<br /><br />Overall, the presentation emphasized the importance of adapting to the challenges posed by the pandemic while ensuring the safety and well-being of research participants, staff, and patients. It provided guidelines and insights for managing clinical research in the midst of the COVID-19 pandemic.

Meta Tag

Concept Clinical Trial Stratification

Concept Safety

Concept Staff Safety

Concept Patient Benefit

Concept Public Health Priority

Keywords

Managing Clinical and Translational Research During COVID-19

Antoinette Wozniak

Jyoti Patel

M. Catherine Pietanza

Buerkley Rose

Amy C. Moore

University of Pittsburgh Hillman Cancer Center

ongoing research

challenges

safety

Clinical Trial Stratification

Safety

Staff Safety

Patient Benefit

Public Health Priority